IER3 anticorps (C-Term) (HRP)
Aperçu rapide pour IER3 anticorps (C-Term) (HRP) (ABIN7999154)
Antigène
Voir toutes IER3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Fonction
- Anti-IER3 Antibody HRP Conjugated
-
Réactivité croisée (Details)
- No cross-reactivity with other proteins
-
Homologie
- Human IER3 shares 85% amino acid (aa) sequence identity with mouse IER3.
-
Purification
- Immunogen affinity purified.
-
Immunogène
- A synthetic peptide corresponding to a sequence at the C-terminus of human IER3. Human IER3 shares 85% amino acid (aa) sequence identity with mouse IER3.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4.
-
Stock
- -20 °C
-
Stockage commentaire
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing.
-
Date de péremption
- 12 months
-
-
- IER3 (Immediate Early Response 3 (IER3))
-
Autre désignation
- IER3
-
Sujet
-
Background: This gene functions in the protection of cells from Fas- or tumor necrosis factor type alpha-induced apoptosis. Partially degraded and unspliced transcripts are found after virus infection in vitro, but these transcripts are not found in vivo and do not generate a valid protein.
Gene Full Name: immediate early response 3
-
ID gène
- 8870
-
UniProt
- P46695
-
Pathways
- Regulation of Carbohydrate Metabolic Process
Antigène
-